LENZ Therapeutics, Inc. (LENZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

17.81

+0.15

(+0.85%)

As of 11:33AM EDT. Market open.

Major holders

Insider roster

Insider transactions

Currency in USD

Insider purchases - Last 6 months	Shares	Trans
Purchases	0	0
Sales	N/A	0
Net shares purchased (sold)	0	0
Total insider shares held	1.41M	N/A
% net shares purchased (sold)	N/A	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
CHEVALLARD DANIEL R Chief Financial Officer	Purchase at price 15.68 per share.	Direct	49,988	14 May 2024	3,188
MCCOLLUM JAMES W Director	Purchase at price 15.99 per share.	Indirect	501,093	13 May 2024	31,332
RA CAPITAL MANAGEMENT, L.P. Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Indirect	0	21 Mar 2024	3,245,785
RA CAPITAL MANAGEMENT, L.P. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.15 per share.	Indirect	2,145,719	21 Mar 2024	998,009
MCCOLLUM JAMES W Director	Stock Award(Grant) at price 0.00 - 2.15 per share.	Indirect	35,761	21 Mar 2024	589,267
ODRICH MARC Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	21 Mar 2024	99,599
SAMSARA BIOCAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.73 - 2.76 per share.	Indirect	1,161,399	12 Apr 2022	424,464
GUTRY PHIL Officer	Purchase at price 2.76 per share.	Direct	13,792	11 Apr 2022	5,000
SAMSARA BIOCAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.06 - 6.19 per share.	Indirect	748,075	24 Jan 2022	123,000
SAMSARA BIOCAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.05 - 6.06 per share.	Indirect	591,748	20 Jan 2022	97,670
SAMSARA BIOCAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.45 per share.	Indirect	166,364	15 Dec 2021	22,329
SAMSARA BIOCAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.15 per share.	Indirect	1,239,496	22 Nov 2021	201,685
SAMSARA BIOCAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 8.61 - 8.65 per share.	Indirect	803,518	15 Oct 2021	93,100
SAMSARA BIOCAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 9.03 - 10.18 per share.	Indirect	1,351,511	08 Oct 2021	145,496
JIMENEZ JOSEPH JR Director	Conversion of Exercise of derivative security at price 0.30 per share.	Direct	14,963	29 June 2021	58,002
KARSEN PERRY A Director		Direct		29 June 2021	8,126
VERSANT VENTURE CAPITAL IV L P Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirect	3,060,000	29 June 2021	180,000
VERSANT VENTURE CAPITAL IV L P Beneficial Owner of more than 10% of a Class of Security		Indirect		29 June 2021	13,871,446
GUTRY PHIL Officer	Conversion of Exercise of derivative security at price 0.30 - 6.11 per share.	Direct	48,092	29 June 2021	102,915
SAMSARA BIOCAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirect	8,500,000	29 June 2021	500,000
SAMSARA BIOCAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security		Indirect		29 June 2021	6,931,623
LEHRER-GRAIWER JOSHUA Chief Executive Officer	Conversion of Exercise of derivative security at price 0.30 per share.	Direct	112,204	29 June 2021	382,139
SHAH SMITAL Director	Purchase at price 17.00 per share.	Indirect	99,994	29 June 2021	5,882
DAVIS JEREL C Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 17.00 per share.	Indirect	3,060,000	29 June 2021	180,000
DAVIS JEREL C Director and Beneficial Owner of more than 10% of a Class of Security		Indirect		29 June 2021	13,871,446
STULTZ KATHERINE VEGA Chief Operating Officer		Direct		29 June 2021	8,126